Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Seviteronel racemate is the racemate form of Seviteronel and is a potent inhibitor of CYP17 lyase.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 6-8 weeks | $ 198.00 | |
5 mg | 6-8 weeks | $ 347.00 | |
25 mg | 6-8 weeks | $ 1,140.00 | |
50 mg | 6-8 weeks | $ 1,490.00 | |
100 mg | 6-8 weeks | $ 1,990.00 | |
1 mL * 10 mM (in DMSO) | 6-8 weeks | $ 382.00 |
Description | Seviteronel racemate is the racemate form of Seviteronel and is a potent inhibitor of CYP17 lyase. |
Targets&IC50 | CYP17 Lyase (human):69 nM |
In vivo | The MDA-PCa-133 xenograft, originating from a clinical castration-resistant prostate cancer (CRPC) bone metastasis, exhibits expression of PSA, the full-length androgen receptor (AR), and the AR-V7 isoform subcutaneously. In a study involving castrated male mice bearing the MDA-PCa-133 tumor, subjects were divided into three groups and underwent 25 days of oral treatment with either a vehicle, Seviteronel (VT-464) at 100 mg/kg twice daily, or Abiraterone Acetate (AA) at 100 mg/kg twice daily. Results demonstrated that both Seviteronel (VT-464) and AA significantly reduced tumor volume by more than two-fold relative to the vehicle group (p<0.05). The study highlights that Seviteronel’s (VT-464) selective CYP17 lyase inhibition is comparably effective to AA’s CYP17 inhibition in reducing tumor volume in this model [2]. |
Synonyms | VT-464 (racemate) |
Molecular Weight | 399.34 |
Formula | C18H17F4N3O3 |
CAS No. | 1375603-36-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (125.21 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Seviteronel racemate 1375603-36-3 Others VT-464 (racemate) VT-464 VT464 racemate VT 464 inhibitor inhibit